BioSpace News Archive

XmAb22841, a CTLA-4 x LAG-3 bispecific antibody, is Xencor’s third tumor microenvironment (TME) activator to enter clinical development

Cardiva Medical, Inc. announced that John Russell, president and chief executive officer of Cardiva Medical, is scheduled to present a corporate overview at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 4:30 p.m. EST in New York, NY.

New Nature Genetics publication describes novel high-throughput single-cell ChIP-seq approach to studying heterogeneity of chromatin states within complex biological systems

Thermo Scientific Orbitrap Eclipse Tribrid Mass Spectrometer reinvigorates high-end protein research with expanded analysis capabilities

Waud Capital Partners, a leading growth-oriented middle-market private equity firm, announced the appointment of Ken Collins as Principal, Healthcare Services, effective immediately.

Thermo Scientific Orbitrap Exploris 480 mass spectrometer designed for high-throughput biopharmaceutical and academic research laboratories

Company Presentation Scheduled for Wednesday June 5, 2019 at 11:40 a.m. Pacific Time.

Cirius Therapeutics announced that Andrew Knudten, M.B.A., will join the company as chief technical officer and will be responsible for advancing the company’s manufacturing and supply chain operations.

ASMS 2019 - Thermo Fisher Scientific, the world leader in serving science, and Evosep, a leading provider of sample preparation technologies for protein-based clinical research, have entered into a collaboration to develop high-throughput clinical research proteomics workflows for profiling large plasma sample cohorts for proteomics, translational research and pharmaceutical applications.

Carisma Therapeutics Inc. announced Robert Petit, Ph.D., as its Chief Scientific Officer.